RxDoctor Payments Data

Nancy McIntyre, DO

Family Medicine · Johns Creek, GANPI 1952628182

Payments from drug & device makers

$7,822in general payments, 2019–2025

Across 434 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$884
  • Lilly USA, LLC$882
  • GSK$763
  • Pfizer$511
  • Inspire Medical Systems, Inc.$462
  • plus $3K from 36 others

What the payments were for

  • Food & beverage$7,819100%
  • Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,822 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$130,905
Medicare patients
275
Services billed
3,891

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide38$54,529
RybelsusSemaglutide11$18,828
TrulicityDulaglutide13$16,391
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$15,645
JardianceEmpagliflozin17$14,297
MounjaroTirzepatide11$12,461
XareltoRivaroxaban11$5,943
ArexvyRsvpref3 Antigen/As01e/Pf16$4,916
SynthroidLevothyroxine Sodium24$2,754
Liothyronine Sodium28$1,202
Valsartan20$616
Bupropion XlBupropion Hcl38$598
Mirtazapine15$553
Rosuvastatin Calcium82$522
Metoprolol Succinate43$497

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,244$73,35849 claims
Lilly USA, LLCTrulicity, Mounjaro$882$28,85324 claims
GSKTrelegy Ellipta, Arexvy$763$20,56135 claims
Boehringer IngelheimJardiance$75$14,29717 claims
Johnson & JohnsonXarelto$15$5,94311 claims
AbbVieSynthroid$884$2,75424 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$47$48796 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Johns Creek

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →